mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.004 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.005 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.006 |